Detalhe da pesquisa
1.
Pharmacogenetics of sulfonylurea: Presence of CYP2C9*2, CYP2C9*3 and a novel allele, CYP2C9*61, in Type 2 diabetes patients under sulfonylurea therapy.
Pak J Pharm Sci
; 33(4(Supplementary)): 1771-1777, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33612460